Fangzhou Inc. (6086.HK) AI-Powered Stock Analysis
See how Fangzhou Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
6086.HK●HKSE
HealthcareDrug Manufacturers - General
HK$0.75
HK$0.08(9.64%)
Hong Kong Market is Open · 14:16
Fangzhou Inc. (6086.HK)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerFangzhou Inc. (6086.HK) Stock Overall Grade
Fangzhou Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Fangzhou Inc.'s overall stock rating.
Forecast
C+Score
53/100Financial Growth
CScore
40/100Fundamental Growth
BScore
62/100Key Ratios
B+Score
74/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Fangzhou Inc. (6086.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 53/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (62/100, B) highlight its stability, while Key Ratios (74/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Fangzhou Inc. stock grade, including financials, comparisons, and forecasts.